Popular Articles

Vast Majority Won't Have Access To Antivirals In Pandemic But Generic Drugs Could Help Prevent Deaths
Almost 90 per cent of the world"s population will not have timely access to affordable supplies of vaccines and antiviral agents in the current influenza pandemic, but it is possible that inexpensive generic drugs that are readily available, even in developing countries, could save millions of lives.

Halozyme Begins Phase 2 Clinical Trial Of Insulin-PH20 In Type 2 Diabetic Patients
Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with Type 2 Diabetes Mellitus. This randomized cross-over design study is designed to compare the postprandial glycemic excursions following a standardized test meal after treatment with either insulin lispro+PH20 or regular insulin+PH20 relative to treatment with lispro (Humalog) alone.
News of the day
Largest Ever Study Of Suicide In The Military
Four of the nation"s leading experts in suicide research, including Dr. John Mann of Columbia University Medical Center, will carry out the largest study of suicide and mental health among military personnel ever undertaken, with $50 million in funding from the U.S. Army. The announcement came today from the National Institute of Mental Health (NIMH), which signed a memorandum of agreement with the Army in October 2008 authorizing the NIMH to undertake the investigation with Army funding. Study investigators aim to move quickly to identify risk and protective factors for suicide among soldiers and provide a science base for effective and practical interventions to reduce suicide rates and address associated mental health problems.
Oncology

Educate Deferred Donors On World Blood Donor Day, June 14th

In recognition of World Blood Donor Day on June 14th, the National Anemia Action Council (NAAC) is providing the online tutorial Anemia & Blood Donation to blood donors who have been deferred because of a low blood count. The free tutorial provides education about the possible causes of a low blood count, potential treatments, and also stresses the importance of communicating a low blood count with a doctor. Without advice, deferred donors may not know it is important to find out what may be causing a low blood count. With the right information, however, they can learn how to raise their blood counts, stay healthy, and try to donate again. In addition to the tutorial, NAAC invites visitors to fill out the Connecting Blood Donors Survey. With results from this survey, NAAC will be able to provide the educational programs desired by deferred blood donors and the healthcare professionals who work with them. Possible programs could include online discussions, chats or lectures, social networking communities, continuing education or an ask the expert service. NAAC encourages healthcare professionals to familiarize themselves with the information in the tutorial and pass it along to their patients, colleagues and to blood donors who have been deferred or may be at risk for a low blood count. Professionals can also submit anemia-related questions to our Ask the Expert service available on the website. National Anemia Action Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):